Retatrutide, a promising dual-action peptide, is rapidly gaining prominence in the field of weight reduction. This exceptional medication combines the functions of GLP-1 receptor agonists and GIP receptor agonists , offering a conceivably more complete approach to addressing obesity. Early resear